Fintel reports that on January 10, 2025, Chardan Capital initiated coverage of Unity Biotechnology (NasdaqGS:UBX) with a Buy ...

Fintel reports that on January 8, 2025, TD Cowen upgraded their outlook for Sana Biotechnology (NasdaqGS:SANA) from Hold to ...

Biotech M&A is heating up, and Mirum Pharmaceuticals stands out. Discover why analysts predict a 50% upside and long-term ...

Legend Biotech is a commercial-stage biotech company specializing in innovative cell therapies. Click here to find out why I ...

Frazier Life Sciences (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the ...

Massachusetts is a hub for biotech: According to the latest MassBio industry snapshot, biopharma accounted for more than 15% of job growth in the entire state in 2023. This month, we’re hearing from ...

Kristin Sherman leads startup Kovina Therapeutics, which is still in the early stages of developing ways to stop human ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

With an aggregate of $11 million raised in an initial Series A funding round, Doron Therapeutics is advancing its lead ...

Zhengye Biotechnology Holding Limited (ZYBT) is planning to raise $7 million in an IPO on the week of January 13th, IPO Scoop reports. The company plans to issue 1,500,000 shares at $4.00-$5.00 per ...

This AI company’s values help drive its booming biotech business.

SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel ...